Filing Flows › Champions Oncology (CSBR) › Who owns the stock
Who owns Champions Oncology (CSBR) stock
27 funds reported Champions Oncology (CSBR) shares in their latest 13F filings, worth $38.5M in all. The largest holder is Battery Management ($14.9M). Last quarter 10 funds added to their stakes and 8 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Battery Management | 2,421,673 | $14.9M | unchanged | 2026-06-30 |
| NEA Management Company, LLC | 1,713,720 | $10.6M | unchanged | 2026-06-30 |
| Vanguard Group | 334,605 | $2.3M | increase | 2025-12-31 |
| Vanguard Capital Management LLC | 301,353 | $1.9M | increase | 2026-06-30 |
| Tocqueville Asset Management L.P. | 295,658 | $1.8M | decrease | 2026-06-30 |
| Morgan Stanley | 235,400 | $1.5M | decrease | 2026-06-30 |
| Bank of America | 214,058 | $1.3M | increase | 2026-06-30 |
| Renaissance Technologies LLC | 139,039 | $856K | decrease | 2026-06-30 |
| BlackRock | 129,848 | $800K | increase | 2026-06-30 |
| Mink Brook Asset Management LLC | 111,338 | $686K | unchanged | 2026-06-30 |
| Geode Capital Management, LLC | 76,300 | $470K | decrease | 2026-06-30 |
| HighTower Advisors, LLC | 41,901 | $258K | increase | 2026-06-30 |
| Vanguard Fiduciary Trust | 33,239 | $205K | increase | 2026-06-30 |
| Northern Trust | 27,910 | $172K | decrease | 2026-06-30 |
| State Street | 26,203 | $161K | unchanged | 2026-06-30 |
Champions Oncology's latest quarter
Champions Oncology, Q1 FY27: revenue $15.2M (+9% year over year), operating margin -2.7%, net loss $426K, operating cash flow −$492K. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most CSBR stock?
By the latest 13F filings: Battery Management ($14.9M); NEA Management Company, LLC ($10.6M); Vanguard Group ($2.3M); Vanguard Capital Management LLC ($1.9M); Tocqueville Asset Management L.P. ($1.8M).
What is the short interest in CSBR?
77,651 shares were sold short at the 2026-10-15 settlement, 9.43% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.